Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

[Problems of drug recognition. Imipramine receptors].

Shimanovskiĭ NL, Sergeev PV.

Farmakol Toksikol. 1986 Jan-Feb;49(1):103-7. Review. Russian. No abstract available.

PMID:
3005029
2.

Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.

Angel I, Goldman ME, Skolnick P, Pisano JJ, Paul SM.

Prog Clin Biol Res. 1985;192:457-64.

PMID:
3001766
3.

Characterization of the endocoid for imipramine recognition sites.

Barbaccia ML, Karoum F, Costa E.

Prog Clin Biol Res. 1985;192:431-40. No abstract available.

PMID:
3001764
4.

Antidepressant binding: implications for the mode of action and the biology of depression.

Hrdina PD.

Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):457-62.

PMID:
6320297
5.

Binding of [3H]imipramine and [3H]desipramine as biochemical tools for studies in depression.

Langer SZ, Raisman R.

Neuropharmacology. 1983 Mar;22(3 Spec No):407-13. Review. No abstract available.

PMID:
6304558
6.

Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

Langer SZ, Galzin AM, Poirier MF, Loo H, Sechter D, Zarifian E.

J Recept Res. 1987;7(1-4):499-521.

PMID:
3040983
7.

5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.

Langer SZ, Lee CR, Schoemaker H, Segonzac A, Esnaud H.

Prog Clin Biol Res. 1985;192:441-55.

PMID:
3001765
8.

Platelet receptor binding studies in affective disorders.

Elliott JM.

J Affect Disord. 1984 Jun;6(3-4):219-39. Review. No abstract available.

PMID:
6146643
9.

Demonstration of an imipramine endacoid in rat brain.

Rehavi M, Ventura I, Sarne Y.

Prog Clin Biol Res. 1985;192:465-72.

PMID:
3001767
10.

Solubilization and partial purification of the high affinity [3H] imipramine binding site from human platelets.

Rehavi M, Skolnick P, Paul SM.

FEBS Lett. 1982 Dec 27;150(2):514-8. No abstract available.

11.
12.
13.

Platelet 3H-imipramine binding, serotonin uptake, and plasma alpha 1 acid glycoprotein in disruptive behavior disorders.

Stoff DM, Ieni J, Friedman E, Bridger WH, Pollock L, Vitiello B.

Biol Psychiatry. 1991 Mar 1;29(5):494-8. No abstract available.

PMID:
1708290
14.

Anti-imipramine antibodies recognize endogenous serotonin uptake and imipramine binding inhibitors.

Tang SW, Cheung S, Strijewski A, Chudzik J, Helmeste D.

Psychiatry Res. 1990 Nov;34(2):205-12.

PMID:
1962863
15.

Decreased platelet 3H-imipramine binding sites in classical migraine.

Geaney DP, Rutterford MG, Elliott JM, Schächter M, Peet KM, Grahame-Smith DG.

J Neurol Neurosurg Psychiatry. 1984 Jul;47(7):720-3.

16.

Molecular aspects of the imipramine 'receptor'.

Davis A.

Experientia. 1984 Aug 15;40(8):783-94. Review. No abstract available.

PMID:
6088274
17.

Decreased platelet 3H-imipramine binding in Parkinson's disease.

Schneider LS, Chui HC, Severson JA, Sloane RB.

Biol Psychiatry. 1988 Jul;24(3):348-51. No abstract available.

PMID:
2840980
18.

[Isolation of substances inhibiting the specific binding of imipramine and serotonin uptake from the brain of the bull].

Mukhin AG, Kladnitskiĭ AV, Kovaleva ES, Kudriakova TB.

Biull Eksp Biol Med. 1985 Aug;100(8):197-9. Russian.

PMID:
2992631
19.
20.

Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.

Dumbrille-Ross A, Tang SW.

Mol Pharmacol. 1983 May;23(3):607-13.

PMID:
6306430

Supplemental Content

Support Center